✦ LIBER ✦

Epoprostenol (prostacyclin, PGI2) binding and activation of adenylate cyclase in platelets of diabetic and control subjects.

✍ Scribed by GL Shepherd; PJ Lewis; IA Blair; C de Mey; J MacDermot

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The use of stable prostaglandins to inve

✍ M. Lombroso; S. Nicosia; R. Paoletti; B.J.R. Whittle; S. Moncada; J.R. Vane 📂 Article 📅 1984 🏛 Elsevier Science 🌐 English ⚖ 650 KB

Effects of heparin on prostacyclin bindi

✍ K. Jaschonek; C. Faul; W. Daiss; H. Weisenbergerl 📂 Article 📅 1986 🏛 Elsevier Science ⚖ 571 KB

Effects of PGI2 on platelet aggregation

✍ Susanna Colli; Marina Lombroso; Paola Maderna; Elena Tremoli; Simonetta Nicosia 📂 Article 📅 1983 🏛 Elsevier Science 🌐 English ⚖ 544 KB

Inhibition of vascular epoprostenol (pro

✍ JM Ritter; MA Orchard; PJ Lewis 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 648 KB

Effect of prostacyclin (PGI2) on platele

✍ A. Dembińska-Kieć; E. Kostka-Trąbka; A. Żmuda; A. Byrska-Danek; K. Bieroń; L. Gr 📂 Article 📅 1982 🏛 Elsevier Science ⚖ 562 KB

Sequential activation of adenylate cycla

✍ Robert Alvarez; John J. Bruno; Jasmine Fazzari 📂 Article 📅 1981 🏛 Elsevier Science 🌐 English ⚖ 41 KB